Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $51.8950 (-1.3%) ($51.8400 - $51.8950) on Mon. Feb. 6, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.48% (three month average) | RSI | 56 | Latest Price | $51.8950(-1.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.3% a day on average for past five trading days. | Weekly Trend | HALO advances 0.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) XBI(42%) IBB(41%) IFRA(40%) IWO(36%) IWM(35%) | Factors Impacting HALO price | HALO will decline at least -1.24% in a week (0% probabilities). VXX(-16%) VIXM(-13%) EDOC(-13%) UUP(-11%) GLD(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.24% (StdDev 2.48%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $51.99 | 5 Day Moving Average | $52.18(-0.55%) | 10 Day Moving Average | $52(-0.2%) | 20 Day Moving Average | $51.99(-0.18%) | To recent high | -12.5% | To recent low | 13.4% | Market Cap | $7.093b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |